According to Molina Healthcare 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 20.0443. At the end of 2022 the company had a P/E ratio of 24.1.
Year | P/E ratio | Change |
---|---|---|
2022 | 24.1 | -13.53% |
2021 | 27.9 | 49.13% |
2020 | 18.7 | 63.3% |
2019 | 11.4 | 13.62% |
2018 | 10.1 | -215.38% |
2017 | -8.73 | -103.11% |
2016 | 280 | 1175.73% |
2015 | 22.0 | -47.05% |
2014 | 41.5 | 38.57% |
2013 | 30.0 | -76.75% |
2012 | 129 | 153.91% |
2011 | 50.8 | 261.72% |
2010 | 14.0 | -27% |
2009 | 19.2 | 139% |
2008 | 8.04 | -57.2% |
2007 | 18.8 | -5.23% |
2006 | 19.8 | -25.59% |
2005 | 26.6 | 19.47% |
2004 | 22.3 | 68.8% |
2003 | 13.2 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() | 11.0 | -45.05% | ๐บ๐ธ USA |
![]() | N/A | N/A | ๐บ๐ธ USA |
![]() | 18.8 | -6.37% | ๐บ๐ธ USA |
![]() | 18.2 | -9.15% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.